Tracer-based lipidomics enables the discovery of disease-specific candidate biomarkers in mitochondrial β-oxidation disorders.
Schwantje M, Mosegaard S, Knottnerus SJG, van Klinken JB, Wanders RJ, van Lenthe H, Hermans J, IJlst L, Denis SW, Jaspers YRJ, Fuchs SA, Houtkooper RH, Ferdinandusse S, Vaz FM.
Schwantje M, et al. Among authors: denis sw.
FASEB J. 2024 Feb 29;38(4):e23478. doi: 10.1096/fj.202302163R.
FASEB J. 2024.
PMID: 38372965